OPTI.L • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold OPTI.L in your mock portfolio yet.
The company is currently loss-making, as indicated by its negative EPS and negative P/E ratio. This suggests that OptiBiotix has yet to achieve sustainable profitability and that investors are paying for future potential rather than current earnings. Without evidence of improving margins or a clear path to profitability, the financial profile remains weak.
The stock has fallen 19.4% over the last month and trades well below its 200-day moving average, signaling a firmly entrenched downtrend. An RSI of 36.13 shows the stock is weak but not yet deeply oversold, leaving room for further downside before a strong technical rebound signal appears. Overall, the technical setup points to ongoing selling pressure and negative momentum.
Alternative data show stagnation rather than growth across key engagement and activity metrics. Website traffic is flat, hiring is nonexistent, and most social media channels are experiencing slight follower declines, pointing to limited marketing traction and muted brand momentum. These signals collectively do not support a near-term growth acceleration narrative.
Taken together, OptiBiotix Health Plc’s negative earnings profile, pronounced share price decline, and weak technicals combine with stagnant alternative data signals to paint a bearish picture. The market appears to be discounting the company’s near-term prospects, and there is little in the current data to suggest an imminent turnaround. Until there is evidence of improving profitability, renewed growth, or stronger engagement metrics, the risk-reward profile skews to the downside.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: